Are they ready to maximize the value of pharmaceuticals in patient care?
NPC at a Glance
NPC is a health policy research organization focused on the critical issues of evidence, the value of medicines for patients, and innovation...more
CER
Do stakeholders think comparative effectiveness research is having an impact on health care decision making? Which organizations are viewed as the leaders on prioritizing, funding, and conducting research? Download our new booklet to find out...more
Value of Rx
Recent NPC research has focused on defining the optimal role and value of pharmaceuticals in the evolving payment and delivery models...more
Individual Treatment Effects
Being "unique" can impact your health care treatments. Learn more about the challenges of individual treatment effects...more
NPC VIDEO
RECENT NEWS
NPC Comments on CMS' Proposed Changes to Protected Classes
March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... more
NPC Asks CMS to Consider Patients’ Individual Treatment Effects In Part D Rulemaking
The National Pharmaceutical Council (NPC) today asked the Centers for Medicare and Medicaid Services (CMS) to... moreICYMI: Articles of Interest (February 2014)
It’s nearly impossible to stay on top of all the articles you need to read when thousands of peer-reviewed... moreCER Tweets of the Week (February 24-28, 2014)
This week, stakeholders on Twitter highlighted a recent study led by NPC and Quintiles, “The GRACE Checklist for... more
AHRQ’s EHC Program: Opportunities for Comment
Interested in imaging techniques or advance care planning (ACP)? The Agency for Healthcare Research and Quality’... moreAs PCORI Funds Head-to-Head Comparisons, Research Must Remain Meaningful, Transparent
In the years since its establishment, the Patient-Centered Outcomes Research Institute (PCORI) has made... moreCMS Report Shows Medicare and Pioneer ACOs Saved $380M
Providers participating in Medicare Accountable Care Organizations (ACOs) saved a total of $380 million in the... moreDisruptive Health Care Efforts Show Results in Cincinnati
Working under the premise that all health care is local, GE launched “Cities Project,” a multi-year effort that... more
NPC, Quintiles Study Tests Tools to Evaluate Quality of Observational Research in Comparative Effectiveness Studies
(Washington, DC, February 25, 2014)—With the growing demand for information about comparative effectiveness and... moreEli Lilly and Company Joins the National Pharmaceutical Council
Washington, D.C. (January 22, 2014)—The National Pharmaceutical Council (NPC) today announced that Eli Lilly and... moreNew Peer-Reviewed Study Shows Mixed Results in ACO Medication Readiness To Achieve Quality, Cost Goals
Washington, D.C.—As Accountable Care Organizations (ACOs) gain traction among both private and public payers, so... moreNPC Comments on the PCORI Methodology Report
(Washington, DC, November 20, 2013)—The National Pharmaceutical Council today commented on the Patient-Centered... moreNPC Comments on CMS' Proposed Changes to Protected Classes
March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... moreThe State of CER and the Environment for Health Care Decision Making
This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (... moreKeeping Our Eye on the CER Ball
Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington... moreLeveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint... more
Leveraging Real-World Data and Analytics in the Device Industry
Thomas Abbott, PhD, head, health care informatics at Johnson & Johnson, Medical Devices and Diagnostics,... moreIMEDS: Sentinel and OMOP Programs
Jane Reese-Coulbourne, MS, ChE, executive director of the Reagan-Udall Foundation, talks about the Food and Drug... moreBig Data: Its Evolving Use and Challenges
William Crown, PhD, chief scientific officer at Optum Labs, discusses how the use and nature of big data in... moreUse of Big and Real-World Data by Pharma: More than Data Warehousing
Real-world data—a subset of big data—is clinical data used for decision-making that did not come from a clinical... moreNPC Asks CMS to Consider Patients’ Individual Treatment Effects In Part D Rulemaking
The National Pharmaceutical Council (NPC) today asked the Centers for Medicare and Medicaid Services (CMS) to... moreICYMI: Articles of Interest (February 2014)
It’s nearly impossible to stay on top of all the articles you need to read when thousands of peer-reviewed... moreCER Tweets of the Week (February 24-28, 2014)
This week, stakeholders on Twitter highlighted a recent study led by NPC and Quintiles, “The GRACE Checklist for... more#TBT: Need Evidence to Inform Health Decisions? Do it GRACEfully with our Checklist
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the... moreNEWS FEEDS
NEWS
NPC, Quintiles Study Tests Tools to Evaluate Quality of Observational Research in Comparative Effectiveness Studies
The GRACE checklist contains 11 items about data and research methods that can be used as an initial screening tool to separate observational studies that meet baseline quality criteria from those that do not.